1 employees
Prothegen is a biotechnology company that develops cutting-edge medicines for precisely regulating cell death.
2021
Prothegen Inc. raised undisclosed on November 3, 2021
Investors: IndieBio
Investors: IndieBio and SOSV - The Accelerator VC